2seventy bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
2seventy bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q3 2024.
  • 2seventy bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.64M, a 73% decline year-over-year.
  • 2seventy bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $14.7M, a 59.9% decline year-over-year.
  • 2seventy bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $32.2M, a 21.6% decline from 2022.
  • 2seventy bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $41M, a 24.9% decline from 2021.
  • 2seventy bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $54.6M, a 10.4% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $14.7M $2.64M -$7.16M -73% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $21.8M $2.39M -$5.36M -69.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $27.2M $4.68M -$4.98M -51.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $32.2M $4.95M -$4.45M -47.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $36.6M $9.8M -$2.41M -19.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $39M $7.74M -$1.95M -20.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $41M $9.67M -$73K -0.75% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $41M $9.41M -$4.92M -34.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $46M $12.2M +$977K +8.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $45M $9.69M -$2.28M -19% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $47.3M $9.74M -$7.37M -43.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $54.6M $14.3M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-07
Q3 2021 $11.2M -$4.03M -26.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $12M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $17.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $15.3M Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.